Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
USP9YP36 is classified as a pseudogene on the human Y chromosome, specifically designated as "USP9Y pseudogene 36"[2][5][6]. Pseudogenes are DNA sequences that resemble functional genes but have lost their original protein-coding capacity through mutation or other mechanisms. No biological function, interaction with drugs, disease association, or biomarker utility is attributed to USP9YP36 in current databases or literature. It does not encode a functional protein and is not known to participate in any pathway or molecular process.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin specific peptidase 9, Y-linked pseudogene 36 (USP9YP36).